 IRVINE, Calif.--BUSINESS WIRE--Axonics, Inc. Nasdaq: AXNX, a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. Axonics is fortunate to have someone of Dr. Lópezs character and extensive experience join our board of directors, said Raymond W. Cohen, CEO of Axonics. Given his thought leaders 